Hancock Whitney Corp
F:HH1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Hancock Whitney Corp
F:HH1
|
US |
|
S
|
Schloss Wachenheim AG
F:SWA
|
DE |
|
Relmada Therapeutics Inc
NASDAQ:RLMD
|
US |
Dividends
Dividend Yield
Hancock Whitney Corp
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Hancock Whitney Corp
HH1 have increased by 111%.
Payout Ratio
Hancock Whitney Corp
| Current Payout | |
| Min Payout | |
| Max Payout | |
| Average Payout | |
| Median Payout |
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for
HH1 is
.
Peers Comparison
Shareholder Yield
Debt Paydown
Not Applicable
Due to the unique financial structures and regulatory environments of banks and insurance companies, the Debt Paydown metric is not applicable for Hancock Whitney Corp.
These institutions manage liabilities differently, focusing more on regulatory compliance and operational liabilities than traditional debt management, making standard debt paydown calculations irrelevant.
Price Appreciation
HH1 Price
Hancock Whitney Corp
| Average Annual Return | 11.92% |
| Standard Deviation of Annual Returns | 12.42% |
| Max Drawdown | -47% |
| Market Capitalization | 6.1B EUR |
| Shares Outstanding | 86 355 000 |
| Percentage of Shares Shorted |
N/A
|